Research & Development

Pioneering pharmaceutical research to develop breakthrough treatments and advance medical science for better patient outcomes.

Explore Our Research
Research & Development at Nova Pharmaceuticals

Our Research Excellence

At Nova Pharmaceuticals, research and development is the cornerstone of our mission to improve human health through innovative pharmaceutical solutions.

Basic Research

Fundamental research in molecular biology, pharmacology, and drug discovery to understand disease mechanisms.

Translational Research

Bridging the gap between laboratory discoveries and clinical applications for patient benefit.

Clinical Research

Comprehensive clinical trials to evaluate safety, efficacy, and therapeutic benefits of new treatments.

Research Focus Areas

Our research spans multiple therapeutic areas with a focus on unmet medical needs and innovative treatment approaches.

Oncology Research

Targeted therapies and immunotherapies

Developing next-generation cancer treatments including targeted therapies, immunotherapies, and personalized medicine approaches.

  • CAR-T cell therapy development
  • Precision oncology biomarkers
  • Combination therapy strategies
Cardiovascular Research

Heart disease prevention and treatment

Advancing cardiovascular medicine through novel drug targets, regenerative therapies, and precision medicine approaches.

  • Novel anti-thrombotic agents
  • Heart failure therapeutics
  • Precision cardiology
Neurology Research

Brain and nervous system disorders

Developing treatments for neurological disorders including neurodegenerative diseases, epilepsy, and mental health conditions.

  • Alzheimer's disease therapeutics
  • Parkinson's disease research
  • Neuroprotective strategies
Infectious Diseases

Antimicrobial and antiviral research

Combatting infectious diseases through novel antibiotics, antivirals, and vaccine development for emerging threats.

  • Antimicrobial resistance solutions
  • Broad-spectrum antivirals
  • Next-generation vaccines

Research Pipeline

Our current research projects across different development stages.

Discovery

Early-stage research and target identification

25+

Active Projects

Preclinical

Laboratory testing and safety evaluation

15+

Active Projects

Clinical Trials

Human testing for safety and efficacy

8+

Active Trials

Regulatory

Approval and market preparation

3+

In Review

State-of-the-Art Facilities

Our research facilities are equipped with cutting-edge technology and staffed by world-class scientists.

We maintain multiple research centers across Russia, each specializing in different therapeutic areas and research methodologies.

5 Research Centers

Across Russia

200+ Scientists

Research Team

Research Excellence

Research Partnerships

Collaborating with leading academic institutions and research organizations worldwide.

Academic Partnerships

Collaborating with leading Russian and international universities for breakthrough research.

  • Moscow State University
  • St. Petersburg University
  • Harvard Medical School
Clinical Partnerships

Working with major medical centers for clinical research and patient studies.

  • Russian Medical Centers
  • International Hospitals
  • Specialized Clinics
Industry Collaborations

Strategic partnerships with pharmaceutical companies and biotech firms.

  • International Pharma
  • Biotech Startups
  • Technology Partners

Advanced Technology & Equipment

Our research facilities are equipped with state-of-the-art technology and cutting-edge equipment to support breakthrough discoveries and innovative pharmaceutical development.

  • High-throughput screening systems
  • Advanced analytical instruments
  • Molecular modeling software
  • Automated synthesis platforms
Advanced Technology and Equipment

Research Publications

Our research findings are published in leading scientific journals, contributing to global medical knowledge.

Recent Publications
Novel Targeted Therapy for Breast Cancer

Nature Medicine, 2024

Dr. Maria Volkov et al.
Cardiovascular Drug Development

The Lancet, 2024

Dr. Alexander Petrov et al.
Neurological Disorder Research

Science, 2024

Dr. Sergei Kozlov et al.
Research Metrics

150+

Publications

2,500+

Citations

25+

Patents

50+

Awards

Join Our Research Team

Be part of groundbreaking pharmaceutical research. Explore career opportunities in our research and development division.